Mifamurtide sodium hydrate

CAS No.	838853-48-8	Cat. No.	BCP49623
Name	Mifamurtide sodium hydrate
Synonyms	MTP-PE sodium hydrate; L-MTP-PE sodium hydrate; CGP 19835 sodium hydrate; CGP19835 sodium hydrate; CGP-19835 sodium hydrate;
Formula	C59H110N6NaO20P	M. Wt	1277.51

Description	Mifamurtide sodium hydrate is the sodium hydrate of mifamurtide. Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities. Muramyl tripeptide phosphatidylethanolamine (MTP-PE), a derivative of the mycobacterial cell wall component MDP, activates both monocytes and macrophages. Activated macrophages secrete cytokines and induce the recruitment and activation of other immune cells, which may result in indirect tumoricidal effects. Liposomal encapsulation of MTP-PE prolongs its half-life and enhances tissue targeting.
Pathways	Others Pathway
Targets	NLR

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.